About this trial
Acute extradural hematoma (EDH) is a potentially life-threatening neurosurgical emergency in children, commonly resulting from traumatic head injury. Early diagnosis and timely surgical intervention are critical factors influencing neurological recovery and overall outcome. Despite advances in neuroimaging and surgical techniques, the clinical presentation, management strategies, and outcomes of pediatric EDH remain variable
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Pediatric patients (<18 years of age).
Patients with traumatic extradural (epidural) hematoma.
Patients who underwent surgical evacuation of the extradural hematoma.
Disqualifiers
Patients with coagulopathy.
Patients with autoimmune disorders.
Patients with a previous operation for extradural hematoma.
Patients with associated intracranial hematomas (e.g., subdural hematoma, subarachnoid hemorrhage, or brain contusion).
Trial population
Pediatric patients aged 0-18 years with acute traumatic extradural hematoma following head injury who are treated surgically at the participating neurosurgical center.
Trial design
Cohort
Other
Treatments tested in this trial
evacuation of hematoma
Procedure/Surgeryemergency craniotomy
Treatment groups
Trial outcomes
Primary outcomes
Neurological outcome assessed by the King's Outcome Scale for Childhood Head Injury (KOSCHI)
Neurological outcome measured using the King's Outcome Scale for Childhood Head Injury (KOSCHI). Scores range from 1 to 5A/5B according to the scale. Higher scores indicate better neurological recovery.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.